{"id":685,"date":"2021-03-22T15:02:10","date_gmt":"2021-03-22T06:02:10","guid":{"rendered":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/?page_id=685"},"modified":"2025-01-09T09:16:43","modified_gmt":"2025-01-09T00:16:43","slug":"%e9%a0%ad%e9%a0%b8%e9%83%a8%e7%99%8c","status":"publish","type":"page","link":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/medical\/chemo\/%e9%a0%ad%e9%a0%b8%e9%83%a8%e7%99%8c\/","title":{"rendered":"\u982d\u9838\u90e8\u764c"},"content":{"rendered":"<div class=\"container\">\n<div class=\"inner80\">\n<div class=\"res\">\n<h3 class=\"ttlShikaku fontMax mt-5\" style=\"margin-bottom: 30px;\">\u982d\u9838\u90e8\u764c<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/wp-content\/uploads\/2021\/03\/\u982d\u981a\u90e8\u764c_0131203.pdf\">0131203 Cetuximab\u5358\u5264(250mg\/m2)<\/a><\/li>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/wp-content\/uploads\/2021\/07\/0131208.pdf\">0131208 biweekly Cetuximab\u5358\u5264(500mg\/m2)<\/a><\/li>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/media\/013187-Docetaxel70mg.pdf\">013187 Docetaxel(70mg\/m\u00b2,d1)+Herceptin6(\u7d99\u7d9a)<\/a><\/li>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/wp-content\/uploads\/2021\/07\/013431.pdf\">013431 \u30101\u56de\u5206\u3011PE(PTX+C-mab)(\u7d99\u7d9a)<\/a><\/li>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/wp-content\/uploads\/2021\/07\/013500.pdf\">013500 Pembrolizumab(200mg\/body)<\/a><\/li>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/wp-content\/uploads\/2021\/03\/\u5171\u901a_900001.pdf\">900001 Nivolumab(240mg\/body, q14)<\/a><\/li>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/wp-content\/uploads\/2021\/07\/900005.pdf\">900005 Pembrolizumab(400mg\/body) ,q42<\/a><\/li>\n<li><a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/cms\/wp-content\/uploads\/2021\/07\/900007\u2460.pdf\">900007 Nivolumab(480mg\/body d1) ,q28<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u982d\u9838\u90e8\u764c 0131203 Cetuximab\u5358\u5264(250mg\/m2) 0131208 biweekly Cetuximab\u5358\u5264(500mg\/m2) 013187 Docetaxel(70mg\/m\u00b2,d1)+Hercept [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":510,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/pages\/685"}],"collection":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/comments?post=685"}],"version-history":[{"count":12,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/pages\/685\/revisions"}],"predecessor-version":[{"id":2556,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/pages\/685\/revisions\/2556"}],"up":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/pages\/510"}],"wp:attachment":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/hp-drug\/pharm\/wp-json\/wp\/v2\/media?parent=685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}